John Vaughn, MD, MS (@johnvaughnmd) 's Twitter Profile
John Vaughn, MD, MS

@johnvaughnmd

Lymphoma and transplant specialist at @NYULangone

ID: 424562683

linkhttps://nyulangone.org/doctors/1649690884/john-l-vaughn calendar_today29-11-2011 22:45:39

474 Tweet

547 Followers

998 Following

Vincent Rajkumar (@vincentrk) 's Twitter Profile Photo

If you have a good presentation at #ASH24 that you would like considered for publication in Blood Cancer Journal Nature Portfolio feel free to discuss with me during the meeting. BCJ impact factor is 12.9

John Vaughn, MD, MS (@johnvaughnmd) 's Twitter Profile Photo

Should every patient with newly diagnosed TP53 mutated MCL be treated with the BOVen regimen, assuming no financial or other barriers to treatment? #lymsm

Guilherme Perini, MD (@guiperinimd) 's Twitter Profile Photo

Real world Burkitt Lymphoma is different from clinical trials, especially in LMIC. Data from Colômbia confirms a higher mortality... doi.org/10.1016/j.cane…

John Vaughn, MD, MS (@johnvaughnmd) 's Twitter Profile Photo

Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial ashpublications.org/blood/article/…

Michael Wang, MD (@michaelwangmd) 's Twitter Profile Photo

Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma | Journal of Clinical Oncology. Hot from press! ascopubs.org/doi/10.1200/JC…

Richard Buka 💙 (@richardbuka) 's Twitter Profile Photo

1/ Pleased to have been involved in this study in British Journal of Haematology that looks at secondary & idiopathic polycythaemia. This is not a fashionable area but a big deal that takes up a lot of time in the clinic. We looked at management and thrombosis rates in two large centres in England.

1/ Pleased to have been involved in this study in <a href="/BrJHaem/">British Journal of Haematology</a> that looks at secondary &amp; idiopathic polycythaemia. This is not a fashionable area but a big deal that takes up a lot of time in the clinic. We looked at management and thrombosis rates in two large centres in England.
Brian Shaffer (@brianshaffermd) 's Twitter Profile Photo

Updated allogeneic stem cell donor guidelines from the CIBMTR/NMDP. A collaborative effort with many wonderful colleagues. Guidelines are adapted for donor selection when using PTCY. sciencedirect.com/science/articl…

NEJM (@nejm) 's Twitter Profile Photo

In a patient with pathogenic ZAP70 mutations and HPV19-integrated SCC, restoring T-cell receptor signaling by stem-cell transplantation resolved HPV-related disease, revealing a direct oncogenic role for β-HPV in immunodeficiency. Read the Brief Report: nej.md/4lTiTCC

In a patient with pathogenic ZAP70 mutations and HPV19-integrated SCC, restoring T-cell receptor signaling by stem-cell transplantation resolved HPV-related disease, revealing a direct oncogenic role for β-HPV in immunodeficiency. Read the Brief Report: nej.md/4lTiTCC
Toby Eyre (@tobyeyre82) 's Twitter Profile Photo

Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis ashpublications.org/bloodadvances/…

JAMA Network Open (@jamanetworkopen) 's Twitter Profile Photo

This survey study found that 21.2% of US medical students experience food insecurity, nearly double the national household average. ja.ma/4n65sPF @basselshanab Pavan Khosla

This survey study found that 21.2% of US medical students experience food insecurity, nearly double the national household average. ja.ma/4n65sPF @basselshanab <a href="/PavanKhosla_/">Pavan Khosla</a>
Vincent Rajkumar (@vincentrk) 's Twitter Profile Photo

Just out in the New England Journal of Medicine! Our comprehensive Review on MGUS: Monoclonal Gammopathy of Undetermined Significance NEJM nejm.org/doi/full/10.10… 5% of people over age 50 have MGUS. Every physician needs to know and understand MGUS. Lots of Tables and

Just out in the New England Journal of Medicine!

Our comprehensive Review on MGUS: Monoclonal Gammopathy of Undetermined Significance <a href="/NEJM/">NEJM</a> nejm.org/doi/full/10.10…

5% of people over age 50 have MGUS. Every physician needs to know and understand MGUS.  Lots of Tables and
Raul Cordoba, MD, PhD (@drraulcordoba) 's Twitter Profile Photo

#Hematology Risk of central nervous system versus systemic relapse in patients with diffuse large B‐cell #lymphoma #DLBCL treated with R‐CHOP: What should we focus on? - Klanova - 2025 - ⁦HemaSphere Journal (IF = 14.6)⁩ - #lymsm onlinelibrary.wiley.com/doi/10.1002/he…